Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause Covid-19? 139 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 139 reports of Covid-19 have been filed in association with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (PLUVICTO). This represents 1.3% of all adverse event reports for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.
139
Reports of Covid-19 with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
1.3%
of all LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN reports
8
Deaths
5
Hospitalizations
How Dangerous Is Covid-19 From LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN?
Of the 139 reports, 8 (5.8%) resulted in death, 5 (3.6%) required hospitalization.
Is Covid-19 Listed in the Official Label?
Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.
What Other Side Effects Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause?
General physical health deterioration (4,332)
Ill-defined disorder (3,600)
Death (1,179)
Disease progression (286)
Malignant neoplasm progression (251)
Laboratory test abnormal (233)
Prostatic specific antigen increased (212)
Fatigue (177)
Anaemia (154)
Platelet count decreased (130)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Alternatives Have Lower Covid-19 Risk?
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTROPIN ALFA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYMECYCLINE
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYRICA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYSERGIDE